pharmacoeconomic guidelines for portugal

1
INTERNATIONAL RESEARCH & OPINION --------------------------------------------------" Regulatory and Healthcare News Pharmacoeconomic guidelines for Portugal Guidelines for the conduct of pharmacoeconomic studies have been published in Portugal, reports Scrip. They were developed by an expert panel following the publication of new legislation in Portugal allowing health authorities to request pharmacoeconomics studies from drug companies for the reimbursement of new medicines. The guidelines provide a model format for economic evaluations as well as recommen- dations regarding: analysis techniques, data use, evaluation of therapeutic efficacy, cost measurement, time frames, populations and reference products. They were made public in December 1998 at a meeting organised by the Health Ministry and the pharmacy and medicine institute Infarmed. Portugal iswes cost-benefit guidelines. Scrip 2400: 5, 6 Jan 1999 _ .. 1173-5503I99I01!MHlOO111$01.00 0 Adlalnternatlonal Limited 11189. All rlghta..-wcl PharmacoEconomics & Outcomes News 23 Jan 11189 No. 1811

Post on 23-Dec-2016

215 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Pharmacoeconomic guidelines for Portugal

INTERNATIONAL RESEARCH & OPINION

--------------------------------------------------" Regulatory and Healthcare News

Pharmacoeconomic guidelines for Portugal

Guidelines for the conduct of pharmacoeconomic studies have been published in Portugal, reports Scrip.

They were developed by an expert panel following the publication of new legislation in Portugal allowing health authorities to request pharmacoeconomics studies from drug companies for the reimbursement of new medicines. The guidelines provide a model format for economic evaluations as well as recommen­dations regarding: analysis techniques, data use, evaluation of therapeutic efficacy, cost measurement, time frames, populations and reference products. They were made public in December 1998 at a meeting organised by the Health Ministry and the pharmacy and medicine institute Infarmed. Portugal iswes cost-benefit guidelines. Scrip 2400: 5, 6 Jan 1999 _ ..

1173-5503I99I01!MHlOO111$01.000 Adlalnternatlonal Limited 11189. All rlghta..-wcl PharmacoEconomics & Outcomes News 23 Jan 11189 No. 1811